- Release Date: 27/06/23 15:46
- Summary: MHRA approval for ATL1102 Phase IIb DMD clinical trial in UK
- Price Sensitive: Yes
- Download Document 116.52KB
Ann: MHRA approval for ATL1102 Phase IIb DMD clinical trial in UK
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.9¢ |
Change
-0.003(4.17%) |
Mkt cap ! $62.20M | |||
| Open | High | Low | Value | Volume |
| 7.2¢ | 7.3¢ | 6.9¢ | $100.8K | 1.426M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 444999 | 6.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.2¢ | 135024 | 1 |
View Market Depth
| Last trade - 16.10pm 30/04/2024 (20 minute delay) ? |
|
|||||
|
Last
7.0¢ |
Change
-0.003 ( 1.41 %) |
||||
| Open | High | Low | Volume | ||
| 7.2¢ | 7.3¢ | 7.0¢ | 150480 | ||
| Last updated 15.59pm 30/04/2024 ? | |||||
| PER (ASX) Chart |